The conduction and cardiac sympathetic systems: metabolic aspects

Area of Science:

• Cardiovascular Physiology
• Cellular Metabolism
• Cardiac Electrophysiology

Background:

• The cardiac conduction system's metabolic profile differs significantly from the myocardium.
• Understanding these differences is crucial for explaining varying tissue susceptibility to ischemic events.

Purpose of the Study:

• To investigate the metabolic and energetic characteristics of the calf heart conduction system.
• To correlate metabolic features with the system's tolerance to ischemia.
• To characterize noradrenaline release during ischemia in a rat heart model.

Main Methods:

• Biochemical analysis of enzyme activity (glycolytic, mitochondrial) and cellular space in calf heart conduction tissues.
• Assessment of adenosine triphosphate (ATP) activities to estimate energy demands.
• Perfusion studies in isolated rat hearts to monitor noradrenaline release during induced ischemia.

Main Results:

• Conduction system exhibits 50% lower glycolytic and 70% lower mitochondrial enzyme/space compared to myocardium.
• Energy demands are reduced by over 50%, correlating with decreased myofibrillar space.
• Sinoatrial and atrioventricular nodes show high hypoxia susceptibility, unlike His-Purkinje system.
• Noradrenaline release during ischemia in rats occurs in three phases: sympathetic stimulation-dependent, carrier-mediated efflux, and membrane leakage.

Conclusions:

• Reduced energy demand and increased reliance on anaerobic glycolysis contribute to the conduction system's ischemia tolerance.
• Specific nodes (SA, AV) are more vulnerable to hypoxia due to their metabolic or structural characteristics.
• Noradrenaline release during ischemia is a complex, multi-phasic process involving neuronal reuptake and membrane integrity.